Helena M. Fitch

Suggest Changes
  • Citations Per Year
Learn More
This phase 1 trial was conducted to evaluate the safety and tolerance of didanosine (ddI) in subjects with AIDS or AIDS-related complex (ARC) who previously had demonstrated hematologic intolerance(More)
  • 1